Repeated ingestion of the leaf extract from Morus alba reduces insulin resistance in KK-Ay mice

Nutrition Research

Volumn 31, Issue 11, 2011, Pages 848-854

  Tanabe, Kenichi ^a   Nakamura, Sadako ^a   Omagari, Katsuhisa ^a   Oku, Tsuneyuki ^a  

^a UNIVERSITY OF NAGASAKI   (Japan)

Author keywords

Antidiabetic effect; Diabetes mellitus; Insulin resistance; KK Ay mice; Morus alba

Indexed keywords

GLUCOSE; INSULIN; MULBERRY EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SCREENING; EPIDIDYMIS FAT; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTESTINE MUCOSA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT LEAF; POSTPRANDIAL STATE; PRIORITY JOURNAL; TREATMENT DURATION; URINARY EXCRETION; WEIGHT GAIN;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET; DIETARY SUCROSE; FASTING; GLYCOSURIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MICE; MORUS; OBESITY; PLANT EXTRACTS; PLANT LEAVES;

EID: 82455209585     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.09.023     Document Type: Article

References (20)

1. Nuengchamnong N., Ingkaninan K., Kaewruang W., Wongareonwanakij S., Hongthongdaeng B. Quantitative determination of 1-deoxynojirimycin in mulberry leaves using liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal 2007, 44:853-858.
2. Oku T., Yamada M., Nakamura M., Sadamori N., Nakamura S. Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity. Br J Nutr 2006, 95:933-938.
3. Nakamura M., Nakamura S., Oku T. Suppressive response of confections containing the extractive from leaves of Morus alba on postprandial blood glucose and insulin in healthy human subjects. Nutr Metab 2009, 14:6-29.
4. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003, 289:76-79.
5. Ghosh S., Schork N.J. Genetic analysis of non-insulin-dependent diabetes mellitus: the study of quantitative traits. Diabetes 1996, 45:1-14.
6. Turner R.C., Hattersley A.T., Shaw J.T.E., Levy J.C. Type II diabetes: clinical aspects of molecular biology studies. Diabetes 1995, 44:1-10.
7. Chakraborty G., Thumpayil S., Lafontant D.E., Woubneh W., Toney J.H. Age dependence of glucose tolerance in adult KK-Ay mice, a model of non-insulin dependent diabetes mellitus. Lab Anim (NY) 2009, 38:364-368.
8. Castle C.K., Colca J.R., Melchior G.W. Lipoprotein profile characterization of the KKA(y) mouse, a rodent model of type II diabetes, before and after treatment with the insulin-sensitizing agent pioglitazone. Arterioscler Thromb 1993, 13:302-309.
9. Goda T., Suruga K., Komori A., Kuranuki S., Mochizuki K., Makita Y., et al. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats. Br J Nutr 2007, 98:702-710.
10. Miyazawa M., Miyahara T., Sato S., Sakai A. Ninety-day dietary toxicity study of mulberry leaf extract in rats. Shokuhin Eiseigaku Zasshi 2003, 44:191-197. [in Japanese].
11. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969, 22:158-161.
12. Liversy J.H., Hodgkinson S.C., Round H.R., Donald R.A. Effect of time, temperature and freesing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin Biochem 1980, 13:151-155.
13. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
14. Kaur J., Singh P., Sowers J.R. Diabetes and cardiovascular diseases. Am J Ther 2002, 9:510-515.
15. Meyer D., Stasse-Wolthuis M. The bifidogenic effect of inulin and oligofructose and its consequences for gut health. Eur J Clin Nutr 2009, 63:1277-1289.
16. Dehghan-Kooshkghazi M., Mathers J.C. Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the alpha-glucosidase inhibitor acarbose. Br J Nutr 2004, 9:357-365.
17. Oku T., Nakamura S. Digestion, absorption, fermentation, and metabolism of functional sugar substitutes and their available energy. Pure Appl Chem 2002, 74:1253-1261.
18. Srinivasan K., Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res 2007, 125:451-472.
19. Kobayashi Y., Miyazawa M., Kamei A., Abe K., Kojima T. Ameliorative effects of mulberry (Morus alba L.) leaves on hyperlipidemia in rats fed a high-fat diet: induction of fatty acid oxidation, inhibition of lipogenesis, and suppression of oxidative stress. Biosci Biotechnol Biochem 2010, 74:2385-2395.
20. Roelofsen H., Priebe M.G., Vonk R.J. The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes. Benef Microbes 2010, 1:433-437.